• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过肺量计评估来评估一种基于索赔数据的预测模型识别未确诊慢性阻塞性肺疾病(COPD)患者的性能。

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD.

作者信息

Moretz Chad, Annavarapu Srinivas, Luthra Rakesh, Goldfarb Seth, Renda Andrew, Shaikh Asif, Kaila Shuchita

机构信息

Comprehensive Health Insights, Louisville, KY, USA,

Boehringer Ingelheim, Ridgefield, CT, USA.

出版信息

Int J Chron Obstruct Pulmon Dis. 2019 Feb 15;14:439-446. doi: 10.2147/COPD.S187947. eCollection 2019.

DOI:10.2147/COPD.S187947
PMID:30863044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6388795/
Abstract

BACKGROUND

A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of the aforementioned model using prospectively collected spirometry data.

METHODS

A study population aged 40-89 years enrolled in a Medicare Advantage plan with prescription drug coverage or commercial health plan and without a claim for COPD diagnosis was identified from April 1, 2012 to March 31, 2016 in the Humana claims database. This population was stratified into subjects likely or unlikely to have undiagnosed COPD using the claims-based predictive model. Subjects were randomly selected for spirometry evaluation of FEV and FVC. The predictive model was validated using airflow limitation ratio (FEV/FVC <0.70).

RESULTS

A total of 218 subjects classified by the predictive model as likely and 331 not likely to have undiagnosed COPD completed spirometry evaluation. Those predicted to have undiagnosed COPD had a higher mean age (70.2 vs 67.9 years, =0.0012) and a lower mean FEV/FVC ratio (0.724 vs 0.753, =0.0002) compared to those predicted not to have undiagnosed COPD. Performance metrics for the predictive model were: area under the curve =0.61, sensitivity =52.5%, specificity =64.6%, positive predictive value =33.5%, and negative predictive value =80.1%.

CONCLUSION

The claims-based predictive model identifies those not at risk of having COPD eight out of ten times, and those who are likely to have COPD one out of three times.

摘要

背景

莫雷茨等人于2015年开发了一种基于索赔数据的模型,用于预测可能患有未确诊慢性阻塞性肺疾病(COPD)的患者。本研究旨在使用前瞻性收集的肺功能测定数据评估上述模型的性能。

方法

2012年4月1日至2016年3月31日期间,从哈门那索赔数据库中确定了年龄在40 - 89岁、参加了有处方药覆盖的医疗保险优势计划或商业健康计划且无COPD诊断索赔记录的研究人群。使用基于索赔的预测模型将该人群分为可能患有或不太可能患有未确诊COPD的受试者。随机选择受试者进行FEV和FVC的肺功能测定评估。使用气流受限率(FEV/FVC <0.70)对预测模型进行验证。

结果

共有218名被预测模型分类为可能患有未确诊COPD的受试者和331名不太可能患有未确诊COPD的受试者完成了肺功能测定评估。与被预测为没有未确诊COPD的受试者相比,被预测为患有未确诊COPD的受试者平均年龄更高(70.2岁对67.9岁,P = 0.0012),平均FEV/FVC比值更低(0.724对0.753,P = 0.0002)。预测模型的性能指标为:曲线下面积 = 0.61,敏感性 = 52.5%,特异性 = 64.6%,阳性预测值 = 33.5%,阴性预测值 = 80.1%。

结论

基于索赔的预测模型在十次中有八次能识别出没有患COPD风险的人,在三次中有一次能识别出可能患有COPD的人。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd95/6388795/3e45eb102173/copd-14-439Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd95/6388795/5af199cbdc1d/copd-14-439Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd95/6388795/3e45eb102173/copd-14-439Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd95/6388795/5af199cbdc1d/copd-14-439Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd95/6388795/3e45eb102173/copd-14-439Fig2.jpg

相似文献

1
Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD.通过肺量计评估来评估一种基于索赔数据的预测模型识别未确诊慢性阻塞性肺疾病(COPD)患者的性能。
Int J Chron Obstruct Pulmon Dis. 2019 Feb 15;14:439-446. doi: 10.2147/COPD.S187947. eCollection 2019.
2
Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database.利用行政索赔数据库开发和验证一种预测模型,以识别可能患有未确诊的慢性阻塞性肺疾病的个体。
J Manag Care Spec Pharm. 2015 Dec;21(12):1149-59. doi: 10.18553/jmcp.2015.21.12.1149.
3
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.用于识别美国初级保健环境中慢性阻塞性肺疾病的 CAPTURE 工具的判别准确性。
JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128.
4
Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.肺功能对慢性阻塞性肺疾病患者急性加重、医疗保健利用及费用的影响。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 27;11:1689-703. doi: 10.2147/COPD.S108967. eCollection 2016.
5
Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?高危人群中慢性阻塞性肺疾病的检测:诊断检查应包括支气管扩张剂可逆性测试吗?
Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.
6
Bronchodilator response of advanced lung function parameters depending on COPD severity.根据慢性阻塞性肺疾病(COPD)严重程度,晚期肺功能参数的支气管扩张剂反应。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 25;11:2939-2950. doi: 10.2147/COPD.S111573. eCollection 2016.
7
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.《萨尔斯堡 COPD 筛查问卷(SCSQ)的制定和验证》:一项问卷制定和验证研究。
NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.
8
Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.在服务不足的患者人群中过度诊断慢性阻塞性肺疾病。
Int J Chron Obstruct Pulmon Dis. 2013;8:545-9. doi: 10.2147/COPD.S45693. Epub 2013 Nov 12.
9
Comparison of the fixed ratio and the -score of FEV/FVC in the elderly population: a long-term mortality analysis from the Third National Health and Nutritional Examination Survey.老年人群中FEV/FVC固定比值与z评分的比较:来自第三次全国健康与营养检查调查的长期死亡率分析。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 14;13:903-915. doi: 10.2147/COPD.S148421. eCollection 2018.
10
Characteristics of Subjects With Undiagnosed COPD Based on Post-Bronchodilator Spirometry Data.基于支气管扩张剂后肺功能检查数据的未诊断 COPD 患者特征。
Respir Care. 2019 Jan;64(1):63-70. doi: 10.4187/respcare.06296. Epub 2018 Aug 7.

本文引用的文献

1
Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.COPDGene 研究中保比预计值受损的肺活量测定中的纵向表型和死亡率。
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1397-1405. doi: 10.1164/rccm.201804-0663OC.
2
Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes.支气管扩张剂使用前和使用后肺量计对慢性阻塞性肺疾病特征和预后的预测价值。
BMJ Open Respir Res. 2017 Dec 18;4(1):e000213. doi: 10.1136/bmjresp-2017-000213. eCollection 2017.
3
Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database.
利用行政索赔数据库开发和验证一种预测模型,以识别可能患有未确诊的慢性阻塞性肺疾病的个体。
J Manag Care Spec Pharm. 2015 Dec;21(12):1149-59. doi: 10.18553/jmcp.2015.21.12.1149.
4
Early chronic obstructive pulmonary disease: definition, assessment, and prevention.早期慢性阻塞性肺疾病:定义、评估与预防
Lancet. 2015 May 2;385(9979):1778-1788. doi: 10.1016/S0140-6736(15)60647-X.
5
Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013.2013年美国慢性阻塞性肺疾病成年患者的就业及活动受限情况
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):289-95.
6
The clinical and integrated management of COPD.慢性阻塞性肺疾病的临床与综合管理
Sarcoidosis Vasc Diffuse Lung Dis. 2014 May 12;31 Suppl 1:3-21.
7
Development and validation of a claims-based prediction model for COPD severity.基于索赔数据的 COPD 严重程度预测模型的建立与验证。
Respir Med. 2013 Oct;107(10):1568-77. doi: 10.1016/j.rmed.2013.05.012. Epub 2013 Jun 25.
8
Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study.支气管扩张剂预后肺功能作为肺健康研究死亡率的预测因子。
Respir Res. 2011 Oct 12;12(1):136. doi: 10.1186/1465-9921-12-136.
9
Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.确定并描述美国管理式医疗中的 COPD 患者。基于行政索赔数据的回顾性、横断面分析。
BMC Health Serv Res. 2011 Feb 23;11:43. doi: 10.1186/1472-6963-11-43.
10
Can outpatient pharmacy data identify persons with undiagnosed COPD?门急诊药房数据能否识别出未被诊断的 COPD 患者?
Am J Manag Care. 2010 Jul;16(7):505-12.